Collaborative Influenza Vaccine Innovations Centers (CIVICs)
Design and Execution of Clinical Trials and Human Challenge Models, Center for Vaccine Development and Global Health
Clinical Core Name Abbreviation: CVD-CIVIC
The CVD-CIVIC draws on more than four decades of innovative, groundbreaking research on the development, evaluation and deployment of vaccines at the Center for Vaccine Development and Global Health (CVD). CVD-CIVIC embraces a cohesive, collaborative approach to achieving the CIVIC goal of advancing the development of novel influenza vaccines.
Our accomplished, multidisciplinary team brings extensive clinical research and regulatory experience, including the design and performance of clinical trials in all phase of development and in diverse populations, and the design and execution of human challenge studies.
We have in-depth influenza, influenza vaccine and immunology expertise, robust and efficient project management, and strong partnerships with collaborating institutions at Vanderbilt University and The State University of New York (SUNY), Upstate. We have access to state-of-the art clinical and laboratory facilities, and our reach and capacities are extended through our partnerships.
Kathleen Neuzil, MD, MPH
Dr. Neuzil is a Professor of Medicine and Pediatrics, Director of the CVD, and an internationally recognized influenza expert. Dr. Neuzil has led many successful multi-year, multi-site, efforts in vaccinology global health. In her role as principal investigator, she will provide overall leadership and is ultimately responsible for the planning, initiation, implementation, integration, conduct and monitoring of all contract activities. She will serve as the primary liaison with NIH program officers and other CIVIC cores and
James Campbell, MD, MS
Dr. Campbell is a Professor of Medicine and Pediatrics, Center for Vaccine Development and Global Health. He is an expert in Pediatric Infectious Diseases and Vaccinology.
Wilbur Chen, MD, MS
Dr. Chen is an Associate Professor of Medicine, Chief of the Adult Clinical Studies Section for the Center for Vaccine Development and Global Health. He is an expert on the conduct of clinical trials, translational studies, and challenge studies.
Dr. Ortiz is an Associate Professor of Medicine, Center for Vaccine Development and Global Health. He is board certified in internal medicine, pulmonary medicine, and critical care medicine, and has subject matter expertise on influenza.
Marcela Pasetti, PhD
Dr. Pasetti is a Professor of Microbiology and Immunology in the Center for Vaccine Development and Global Health. She is a senior immunologist with 25 years of experience in clinical and vaccine immunology, establishment of immunological assays and analysis of immune responses during clinical and pre-clinical studies.
Marcelo Sztein, MD
Dr. Sztein is a Professor in the Department of Pediatrics, with secondary appointments in the Departments of Medicine and Microbiology and Immunology. Dr. Sztein is also the Chief of the CVD's Cellular Immunology Section and Director of the UMB Flow Cytometry Core Laboratory.
Other Key Staff
Yuanyuan Liang, PhD, Biostatistician – Dr. Liang is a Professor in the Department of Epidemiology and Public Health at the University of Maryland School of Medicine, and the Section Head for Biostatistics at CVD.
Lisa Chrisley, RN, Clinical Research Manager - Ms. Chrisley is the clinical research nurse manager for the Center for Vaccine Development and Global Health. She has over 25 years of nursing experience, including over 19 years of clinical research experience.
Brenda Dorsey, RN, QA Specialists - Ms. Dorsey is the quality assurance specialist for the Center for Vaccine Development and Global Health. Her role is to support Investigators with maintaining regulatory compliance with the terms of the award and the University of Maryland Baltimore Institutional Review Board (UMB-IRB), Human Research Protections Office policies.
Terry Sharp, Director, Grants and Contracts - Ms. Sharp is the grant and contracts administrative director in the Center for Vaccine Development and Global Health. She will serve as the interim Program Manager until one has been put in place. Ms. Sharp has over 37 years of grants and contract administration and program management.